There’s reason to remain bullish about Merck’s growth prospects in the long run. And at a discounted price, the stock could ...

One of the new vaccine advisers picked by U.S. Health Secretary Robert F. Kennedy Jr. has earned thousands of dollars as an ...

Three of the health secretary’s picks to replace fired members of an influential panel that sets U.S. vaccine policies have ...

Two new vaccine advisers tapped by Health and Human Services Secretary Robert F. Kennedy Jr. have served as paid expert ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

Merck & Co., Inc. (NYSE:MRK) is one of the best wide moat stocks to buy now. On June 9, Merck’s preventative antibody shot ...

Merck & Co. Inc. closed 39.23% short of its 52-week high of $134.63, which the company reached on June 25th.

The IPO comes just a few weeks after Caris raised $168 million in a private financing round that took the total raised by the ...

Currently, Merck stock shows potential for another collar setup, with defined risk and reward, though I haven't executed a ...

Merck & Co., Inc. ( NYSE: MRK) Goldman Sachs 46th Annual Global Healthcare Conference June 10, 2025 10:00 AM ET Dean Y. Li - Executive VP & President of Merck Research Laboratories Robert M. Davis - ...

Citizens Financial Group (CFG) will be expanding its share buyback program to $1.5 billion. Pharmaceutical giant Merck (MRK) ...